The magnetic resonance imaging (MRI) findings of Hashimoto's encephalopathy (HE) are variable; images range from having a normal appearance, to showing ischemic lesions, demyelination, or vasogenic edema.
INTRODUCTION
Hashimoto's encephalopathy (HE) is an uncommon autoimmune disease involving the central nervous system and is characterized by high titers of antithyroid antibodies and various neuropsychological symptoms. 1 The clinical manifestations of HE are diverse, and may include minor cognitive impairment, tremors, myoclonus, status epilepticus, and coma. 2 The magnetic resonance imaging (MRI) findings of HE are variable, images range from having a normal appearance, to showing ischemic lesions, demyelination, or vasogenic edema. 3 Herein we report a case of HE with reversible diffuse leukoencephalopathy on MRI.
CASE REPORT
A 57-year-old woman presented with sudden onset of transient dysarthria and dizziness. She underwent a mastectomy 10 years ago for breast cancer. She was healthy until this presentation and took no medication. A neurologic examination revealed dysarthria and mild postural tremor on both arms. Routine blood tests were within normal limits. test that was performed when aphasia occurred are as follows: naming was 0 of 6, fluency was 1 of 4, repetition was 1 of 4, comprehension was 1 of 4. We considered she had global aphasia and postictal confusion due to a complex partial seizure, i.e., ictal aphasia. We added levetiracetam 1,000 mg/day and phenytoin 300 mg/day. Eleven days after admission, her mental status had worsened; she was in a coma with intermittent whole-body myoclonus. On the follow-up EEG, there was an ictal discharge that started from the bifrontal area as a semi-rhythmic theta to delta wave at 4-6 Hz. We administered valproate 900 mg/day.
On day 13, the follow-up MRI showed diffuse confluent high signal intensities on the bilateral cerebral white matter on DWI (A), apparent diffusion coefficient (ADC) mapping (B) and fluid-attenuated inversion recovery (FLAIR) images (C). We considered that the subtle high signal intensity on DWI was due to the T2 shiny effect, and the MRI findings were compatible with vasogenic edema (Fig.   1 ). Cerebrospinal fluid analysis revealed a slightly increased 
DISCUSSION
HE is a rare disease and the prevalence is approximately 2.1/100,000. 4 It is a female-predominant condition, the ratio of men to women is 1:5, and most common age of onset is between 45 and 55. 5 Most patients are affected by Hashimoto's thyroiditis, and some patients are affected by Grave's disease. 6 There is no evidence that the anti-TPO antibody directly affects the central nervous system, and the exact pathogenic mechanism is still unknown. We considered the subtle high signals on DWI as a T2
shine through effect and lesions were exclusively confined to the white matter. Therefore, we interpreted this MRI findings as vasogenic edema and leukoencephalopathy.
The main first-line treatment for HE is methylprednisolone 1,000 mg as an intravenous infusion for 3-5 days.
11
The symptoms usually respond within a week, sometimes as quickly as within a day. In up to 40% of patients, there is no recurrence after the first steroid pulse therapy. 
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